Disclaimer: All information on this section is of a general nature.
Before making any investment decision, you should seek the relevant advice.
State One Research
BARD1 Life Sciences (ASX: BD1) - Lung Cancer Test setback delays path to clinica
On 15 May 2017, BD1 announced the results of a 638-sample lung cancer study using its BARD1 Lung Cancer Test. The study demonstrated that the Test had an overall ROC-AUC score for accuracy in identifying lung cancer of 0.82 in the training sets and 0.725 (read more)
Market Opener - 17 May 2017
Local and Overseas Market Commentary, Today’s Stock Watch, Commodities, Pre-Open Announcements, and Reports & Events (read more)
Daily Resources Overview - 17 May 2017
Leading commodities, LME warehouse inventories, exchange rates, and overseas mining stocks price movements (read more)
Market Opener - 16 May 2017
Local and Overseas Market Commentary, Today’s Stock Watch, Commodities, Pre-Open Announcements, and Reports & Events (read more)
Daily Resources Overview - 16 May 2017
Leading commodities, LME warehouse inventories, exchange rates, and overseas mining stocks price movements (read more)